INSM · NASDAQ
INSMED (INSM) Stock Price & Fundamentals
INSMED (INSM) closed at $473.59 on Oct 9, 2026, up 0.35% from the previous close of $471.96.
Share price, past year
1Y +13.74%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $473.59 |
| Sep 30, 2026 | $469.57 |
| Aug 31, 2026 | $448.07 |
| Jul 31, 2026 | $460.39 |
| Jun 30, 2026 | $437.35 |
| May 29, 2026 | $441.87 |
| Apr 30, 2026 | $413.83 |
| Mar 31, 2026 | $411.48 |
| Feb 27, 2026 | $412.44 |
| Jan 30, 2026 | $432.39 |
| Dec 31, 2025 | $409.04 |
| Nov 28, 2025 | $426.91 |
| Oct 31, 2025 | $414.74 |
Key statistics
- Market cap
- $103.38B
- P/E (TTM)
- —
- EPS (TTM)
- −$4.12
- Revenue (TTM)
- $1.14B
- Net income (TTM)
- −$875.31M
- Shares outstanding
- 218.3M
- Dividend yield
- —
- 52-week range
- $396.61 – $473.59
INSMED's market cap is $103.38B, based on a share price of $473.59 and 218.3M shares outstanding as of Jun 30, 2026.
Financials
INSMED reported revenue of $606.42M for fiscal 2025, up 66.73% from fiscal 2024.
INSMED reported a net loss of $1.28B in fiscal 2025.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $606.42M | +66.7% | −$1.28B | −210.5% | −$6.42 | −$967.58M |
| FY2024ended Dec 31, 2024 | $363.71M | +19.2% | −$913.77M | −251.2% | −$5.57 | −$705.81M |
| FY2023ended Dec 31, 2023 | $305.21M | +24.4% | −$749.57M | −245.6% | −$5.34 | −$549.54M |
| FY2022ended Dec 31, 2022 | $245.36M | +30.2% | −$481.53M | −196.3% | −$3.91 | −$410.32M |
| FY2021ended Dec 31, 2021 | $188.46M | +14.6% | −$434.65M | −230.6% | −$3.88 | −$370.59M |
| FY2020ended Dec 31, 2020 | $164.41M | +20.5% | −$294.09M | −178.9% | −$3.01 | −$225.59M |
| FY2019ended Dec 31, 2019 | $136.47M | +1,287.6% | −$254.34M | −186.4% | −$3.01 | −$292.92M |
| FY2018ended Dec 31, 2018 | $9.84M | — | −$324.28M | −3,297.2% | −$4.22 | −$271.07M |
| FY2017ended Dec 31, 2017 | $0.00 | — | −$192.65M | — | −$2.89 | −$162.62M |
| FY2016ended Dec 31, 2016 | $0.00 | — | −$176.27M | — | −$2.85 | −$150.91M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $425.49M | −$13.24M | −$0.06 |
| Q1 FY2026ended Mar 31, 2026 | $305.96M | −$163.56M | −$0.76 |
| Q4 FY2025ended Dec 31, 2025 | $263.84M | −$328.49M | −$1.55 |
| Q3 FY2025ended Sep 30, 2025 | $142.34M | −$370.02M | −$1.75 |
| Q2 FY2025ended Jun 30, 2025 | $107.42M | −$321.69M | −$1.70 |
| Q1 FY2025ended Mar 31, 2025 | $92.82M | −$256.58M | −$1.42 |
| Q4 FY2024ended Dec 31, 2024 | $104.44M | −$235.55M | −$1.30 |
| Q3 FY2024ended Sep 30, 2024 | $93.43M | −$220.52M | −$1.27 |
Company profile
- Name
- INSMED Inc
- Ticker
- INSM
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 700 Us Highway 202/206, Bridgewater, NJ 08807
- Incorporated in
- VA
- Fiscal year ends
- December
- SEC CIK
- 0001104506
Recent SEC filings
- Oct 5, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jul 16, 2026
- May 15, 2026
- May 7, 2026
- May 7, 2026
- Apr 7, 2026
Frequently asked questions
What is INSMED's stock price?
INSMED (INSM) closed at $473.59 on Oct 9, 2026, up 0.35% from the previous close of $471.96.
What is INSMED's market cap?
INSMED's market cap is $103.38B, based on a share price of $473.59 and 218.3M shares outstanding as of Jun 30, 2026.
How much revenue does INSMED make?
INSMED reported revenue of $606.42M for fiscal 2025, up 66.73% from fiscal 2024.
Does INSMED pay a dividend?
INSMED's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from INSMED Inc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures